谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

PARP Inhibitor Resistance and TP53 Mutations in Patients Treated with Olaparib for BRCA-mutated Cancer: Four Case Reports.

Thomas Collot,Julie Niogret,Marion Carnet,Sandy Chevrier,Etienne Humblin,Laure Favier,Leila Bengrine-Lefevre,Isabelle Desmoulins,Laurent Arnould,Romain Boidot

Molecular Medicine Reports（2020）

引用 15|浏览70
关键词
resistance,PARP inhibitors,TP53,BRCA-mutated cancer,olaparib
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要